+136.7%
FHN vs SBAC
-7.2%
+143.9%
-27.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | -1.1% | +1.0% | 0.0% |
| 7D | +1.2% | -0.8% | +2.0% | +1.2% |
| 30D | -4.7% | +6.9% | -11.6% | -5.2% |
| 3M | +3.5% | -8.2% | +11.8% | +4.2% |
| 6M | +7.8% | -1.6% | +9.5% | +7.9% |
| YTD | +5.9% | -0.1% | +6.0% | +5.7% |
| 1Y | +12.5% | -0.5% | +12.9% | +12.3% |
| All | +136.7% | -7.2% | +143.9% | +135.9% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling